Clinical Trials Related to Bristol-Myers Squibb

Related studies linked through entity extraction aliases.

A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC

Status: UNKNOWN
Phase: PHASE1/PHASE2

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation

Status: RECRUITING
Phase: N/A

Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer

Status: COMPLETED
Phase: PHASE2

A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)

Status: COMPLETED
Phase: N/A

A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure

Status: COMPLETED
Phase: N/A

CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Status: UNKNOWN
Phase: PHASE2/PHASE3

Expanded Access for Anti-IL8

Status: NO_LONGER_AVAILABLE
Phase: N/A

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Status: TERMINATED
Phase: PHASE1

Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Status: TERMINATED
Phase: PHASE2

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Expanded Access for Apixaban

Status: AVAILABLE
Phase: N/A

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab

Status: NO_LONGER_AVAILABLE
Phase: N/A

Expanded Access for Abatacept

Status: NO_LONGER_AVAILABLE
Phase: N/A

Expanded Access for Relatlimab

Status: NO_LONGER_AVAILABLE
Phase: N/A

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

Status: RECRUITING
Phase: N/A

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Status: TERMINATED
Phase: PHASE2